Earnings Review and Free Research Report: Physicians Realty’s Revenue Soared 43.9%; Net Income Climbed 43.8%
Research Desk Line-up: Omega Healthcare Investors Post Earnings Coverage
LONDON, UK / ACCESSWIRE / August 23, 2017 /Pro-Trader Daily has just published a free post-earnings coverage on Physicians Realty Trust (NYSE: DOC) ("Physicians Realty"), which can be viewed by registering at http://protraderdaily.com/optin/?symbol=DOC, following the Company's reporting of its second quarter fiscal 2017 operating results on August 03, 2017. The health care real estate investment outperformed revenue and funds from operations (FFO) estimates. Our daily stock reports are accessible for free, and with those to look forward today you also will be signing up for a complimentary member's account at:
Get more of our free earnings reports coverage from other constituents of the REIT - Healthcare Facilities industry. Pro-TD has currently selected Omega Healthcare Investors, Inc. (NYSE: OHI) for due-diligence and potential coverage as the Company announced on July 26, 2017, its financial results for Q2 2017 which ended on June 30, 2017. Register for a free membership today, and be among the early birds that get access to our report on Omega Healthcare Investors when we publish it.
At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on DOC; also brushing on OHI. With the links below you can directly download the report of your stock of interest free of charge at:
For the second quarter ended June 30, 2017, Physicians Realty's total revenue was $76.60 million, reflecting an increase of 43.9% from revenue of $53.22 million in Q2 2016. As of June 30, 2017, the portfolio was 96.3% leased. The Company's revenue numbers exceeded analysts' expectations of $74.8 million.
Physicians Realty's total expenses were $71.61 million for Q2 2017, an increase of 55.5% from total expenses of $46.06 million in Q2 2016. The increase in expenses was primarily the result of an $8.3 million increase in depreciation and amortization; a $6.7 million increase in operating expenses; and a $7.2 million increase in interest expenses.
For Q2 2017, Physicians Realty's net income grew to $10.3 million compared to net income of $7.2 million for Q2 2016; an increase of 43.8%. The Company's net income attributable to common shareholders was of $9.7 million and diluted earnings per share was $0.06 for the reported quarter.
Physicians Realty's FFO was $32.65 million, or $0.20 per common share, for Q2 2017 compared to FFO of $26.31 million, or $0.19 per common share. The Company's normalized FFO was $37.89 million, or $0.24 per diluted share, for the reported quarter compared to $29.54 million, or $0.22 common share, and OP unit. Physicians Realty's FFO exceeded estimates of $0.23 per share.
Physicians Realty's same-store portfolio, which includes 156 properties representing approximately 48.5% of the Company's net leasable square footage, generated a same-store net operating income (NOI) growth of 1.0% for Q2 2017.
Assets Slated for Disposition
As of June 30, 2017, Physicians Realty had six properties, representing 260,131 square feet of gross leasable area, to be slated for disposition. These assets consist of five assets affiliated with Foundation Healthcare, Inc. and one medical office building in Michigan.
In the quarter ended June 30, 2017, Physicians Realty completed property acquisitions representing an aggregate of 1,284,276 net leasable square feet for an aggregate purchase price of approximately $581.9 million. Total investment activity was approximately $588.2 million for the reported quarter.
Since its press release on June 28, 2017, and through June 30, 2017, the Company completed acquisitions containing an aggregate of 1,223,436 net rentable square feet for $562.3 million.
Physicians Realty's operating partnership entered into two separate purchase and sale agreements with certain subsidiaries and affiliates of Catholic Health Initiatives ("CHI") to acquire 13 medical office facilities located in six states, comprising approximately 676,745 net leasable square feet for an aggregate purchase price of approximately $157.1 million. On June 29, 2017, the Company closed on the acquisition of eight medical office buildings totaling 492,338 square feet located in Arkansas, Minnesota, North Dakota, Nebraska, Tennessee, and Texas for a purchase price of $124.2 million.
On June 29, 2017, Physicians Realty closed the acquisition of an 85,847 square foot medical office facility in Carmel, Indiana, for a purchase price of approximately $33.1 million. This multi-tenant facility is 87% leased with 73% occupied by St. Vincent Health for a remaining term of approximately 6 years.
On June 29, 2017, Physicians Realty closed the acquisition of a 120,158 square foot medical office facility in Fishers, Indiana, for a purchase price of approximately $60.8 million. This multi-tenant facility is 100% leased with 86% occupied by various 10-year St. Vincent Health leases. The first year unleveraged yield on the St. Vincent Health investments described above is expected to be approximately 4.7%.
On June 30, 2017, Physicians Realty closed the acquisition of a 458,396 square foot medical office facility in Dallas, Texas, for a purchase price of approximately $290.0 million. This multi-tenant facility is 95% leased with 40% occupied by US Oncology (McKesson) and 55% occupied by Baylor Health Care. This 10-story medical office building was built in 2011 and has 8.6 years remaining on the in-place leases.
On June 30, 2017, Physicians Realty closed the acquisition of a 66,697 square foot medical office facility in Appleton, Wisconsin, for a purchase price of approximately $27.9 million. This facility is 100% leased by a group of physicians under NOVO Health. The first year unlevered yield on this investment is expected to be approximately 6.5%.
On April 07, 2017, Physicians Realty sold four medical office buildings, representing an aggregate 80,292 square feet, in Georgia, for approximately $18.2 million and recognized a gain on the sale of approximately $5.3 million.
2017 Acquisition Guidance
Physicians Realty expects to close between $1.2 billion and $1.4 billion of total real estate investments in 2017 subject to favorable capital market conditions.
On Tuesday, August 22, 2017, Physicians Realty Trust's stock closed the trading session at $18.18, marginally up 0.17% from its previous closing price of $18.15. A total volume of 1.13 million shares were exchanged during the session. Shares of the Company have a PE ratio of 77.69 and have a dividend yield of 5.06%. The stock currently has a market cap of $3.30 billion.
Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charter holder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: (917) 341.4653
Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
© 2017 Accesswire. All Rights Reserved.